Initial results of thoracic endovascular repair for uncomplicated type B aortic dissection involving the arch vessels using a semicustom-made thoracic fenestrated stent graft

Journal of Vascular Surgery
Soichiro FukushimaTadashi Akiba

Abstract

Thoracic endovascular aortic repair (TEVAR) for selected type B aortic dissection (TBAD) is a standard treatment; however, TBAD involving the aortic arch is difficult to treat because of the need for arch vessel reconstruction. We report our initial results of TEVAR for uncomplicated TBAD involving the arch vessels using a semicustom-made fenestrated stent graft. This is a retrospective study of 24 patients treated by fenestrated (F group) or debranching (D group) TEVAR from August 2011 to July 2017. The patients in the F group received the Najuta semicustom-made fenestrated stent graft (Kawasumi Laboratories, Tokyo, Japan). The fenestrated graft ensures sufficient sealing at the proximal healthy aorta without the need for arch vessel reconstruction. The primary end point was aorta-related mortality; the secondary end points were technical success and major adverse events (stroke, type IA endoleak, retrograde type A aortic dissection, and secondary intervention). During the study period, we treated 65 TBAD cases by TEVAR, including 17 complicated cases. Of the 48 uncomplicated cases, 24 underwent TEVAR with arch vessel involvement (13 in the F group and 11 in the D group). The technical success rates in the F and D groups were ...Continue Reading

References

Apr 22, 2008·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Jacques KpodonuEdward B Diethrich
Aug 2, 2011·Journal of Vascular and Interventional Radiology : JVIR·Norio HongoHiromu Mori
Feb 12, 2013·Journal of Vascular Surgery·Frédéric CochennecJean-Pierre Becquemin
Mar 16, 2013·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Koichi YuriHideo Adachi
Jul 5, 2013·Annals of Vascular Diseases·Satoshi KawaguchiRyohei Yozu
Aug 8, 2013·Circulation. Cardiovascular Interventions·Christoph A NienaberUNKNOWN INSTEAD-XL trial
Sep 5, 2013·Journal of Vascular Surgery·Paola De RangoFabio Verzini
Jan 21, 2014·Annals of Surgery·Ludovic CanaudMatt M Thompson
Apr 2, 2014·The Journal of Thoracic and Cardiovascular Surgery·Stéphan HaulonTara Mastracci
Dec 3, 2014·Journal of Vascular Surgery·Benjamin O PattersonMatt M Thompson
May 20, 2015·The Annals of Thoracic Surgery·Yoshihiko KurimotoKatsuhiko Nakanishi
Jun 18, 2016·Journal of Vascular Surgery·Nikolaos TsilimparisTilo Kölbel
Oct 26, 2016·Journal of Vascular Surgery·R James ValentineThomas C Naslund
Nov 1, 2016·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Yuji KanaokaTakeshi Baba
Feb 22, 2017·Journal of Vascular Surgery·Igor VoskresenskyAdam W Beck
Dec 23, 2017·Journal of Vascular Surgery·Thomas F X O'DonnellMark F Conrad

❮ Previous
Next ❯

Citations

Feb 7, 2019·The Cochrane Database of Systematic Reviews·Dominic PangPaul Bachoo
Jun 18, 2019·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·George Joseph
Aug 29, 2020·VASA. Zeitschrift für Gefässkrankheiten·Sigrid NikolChristine Espinola-Klein
Feb 11, 2021·Experimental Animals·Soichiro FukushimaHirotaka James Okano
Nov 13, 2020·Seminars in Thoracic and Cardiovascular Surgery·Lixin WangWeiguo Fu
Jan 14, 2022·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·George JosephRaj Sahajanandan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.